Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ABCL
- Price
- 3.41
- Stock movement up
- +0.13 (3.12%)
- Company name
- Abcellera Biologics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.28B
- Ent value
- 1.47B
- Price/Sales
- 38.98
- Price/Book
- 1.19
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 58.67%
- 3 year return
- -30.39%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABCL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 38.98 |
| Price to Book | 1.19 |
| EV to Sales | 44.69 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 298.83M |
| EPS (TTM) | -0.60 |
| FCF per share (TTM) | -0.67 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 32.96M |
| Gross profit (TTM) | -59.24M |
| Operating income (TTM) | -308.06M |
| Net income (TTM) | -175.80M |
| EPS (TTM) | -0.60 |
| EPS (1y forward) | -0.49 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -179.73% |
| Operating margin (TTM) | -934.58% |
| Profit margin (TTM) | -533.32% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 126.64M |
| Net receivables | 63.24M |
| Total current assets | 742.88M |
| Goodwill | 47.81M |
| Intangible assets | 52.58M |
| Property, plant and equipment | 0.00 |
| Total assets | 1.39B |
| Accounts payable | 34.80M |
| Short/Current long term debt | 71.40M |
| Total current liabilities | 79.57M |
| Total liabilities | 314.73M |
| Shareholder's equity | 1.08B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -119.66M |
| Capital expenditures (TTM) | 76.88M |
| Free cash flow (TTM) | -196.54M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -16.31% |
| Return on Assets | -12.62% |
| Return on Invested Capital | -16.23% |
| Cash Return on Invested Capital | -18.14% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.13 |
| Daily high | 4.40 |
| Daily low | 4.13 |
| Daily Volume | 4.11M |
| All-time high | 53.20 |
| 1y analyst estimate | 9.29 |
| Beta | 0.65 |
| EPS (TTM) | -0.60 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 11 Nov 2025 |
Downside potential
Loading...
Downside potential data
| ABCL | S&P500 | |
| Current price drop from All-time high | -91.92% | -1.46% |
| Highest price drop | -96.37% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -79.92% | -10.99% |
| Avg time to new high | 196 days | 12 days |
| Max time to new high | 1145 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.28B
Marketcap category
Small-cap
Description
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Employees
596
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page